Abstract
The human immunodeficiency virus (HIV-1) has evolved into a viral quasispecies with a high replication capacity or fitness. Antiretroviral drugs potently inhibit replication of the wild-type virus, but HIV-1 responds by selection of drug-resistant variants. Here we review, in brief, the evolution of resistance to protease inhibitors that is characterized by severe fitness losses and an abundance of subsequent repair strategies. The possibility to restrict HIV-1 fitness is discussed in relation to the control of HIV-1 pathogenesis
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 298-305 |
Journal | Journal of biomedical science |
Volume | 6 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1999 |